Locomotion and stereotypy induced by scopolamine: Contributions of muscarinic receptors near the pedunculopontine tegmental nucleus

Brain Research

Volumn 775, Issue 1-2, 1997, Pages 144-155

  Mathur, Anuradha ^a   Shandarin, Anna ^a   Laviolette, Steven R ^a   Parker, Jayson ^a   Yeomans, John S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antimuscarinic; Cholinergic; Dopaminergic; Hyperactivity; Mesopontine; Psychosis

Indexed keywords

CARBACHOL; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; STEREOTYPY; TEGMENTUM;

ANIMALS; CARBACHOL; DOPAMINE ANTAGONISTS; HALOPERIDOL; MALE; MESENCEPHALON; MICROINJECTIONS; MOTOR ACTIVITY; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; PONS; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SCOPOLAMINE; STEREOTYPED BEHAVIOR;

EID: 0031473476     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00928-1     Document Type: Article

References (65)

1. Abood L.G., Biel J.H. Anticholinergic psychotomimetic agents. Int. Rev. Neurobiol. 4:1962;217-273.
2. Anisman H., Cygan D. Central effects of scopolamine and (+)-amphetamine on locomotor activity: interaction with strain and stress variables. Neuropsychopharmacology. 14:1975;835-840.
3. Arnfred T., Randrup A. Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behavior. Acta Pharmacol. Toxicol. 26:1968;384-394.
4. Barbeau A. A pathogenesis of Parkinson's disease: a new hypothesis. J. Can. Med. Assoc. 87:1962;802-807.
5. Baumgold J., Abood L.G., Aronstam R. Studies on the relationship of binding affinity to psychoactive and anticholinergic potency of a group of psychotomimetic glycolates. Brain Res. 124:1977;331-340.
6. Bechara A., van der Kooy D. The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preference produced by morphine and amphetamine. J. Neurosci. 9:1989;3400-3409.
7. Bechara A., van der Kooy D. Lesions of the tegmental pedunculopontine nucleus: effects on the locomotor activity induced by morphine and amphetamine. Pharmacol. Biochem. Behav. 42:1992;9-18.
8. Beninato M., Spencer R.F. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus. Brain Res. 412:1987;169-174.
9. Blaha C.D., Winn P. Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental-lesioned rats. J. Neurosci. 13:1993;1035-1044.
10. Blaha C.D., Allen L.F., Das S., Inglis W.L., Latimer M.P., Vincent S.R., Winn P. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine-lesioned, and laterodorsal tegmental-lesioned rats. J. Neurosci. 16:1996;714-722.
11. Bolam J.P., Francis C.M., Henderson Z. Cholinergic input to dopaminergic neurons in the substantia nigra: a double immunocytochemical study. Neuroscience. 41:1991;483-494.
12. Bolden C., Cusack B., Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 260:1991;576-580.
13. Brudzynski S., Wu M., Mogenson G.J. Modulation of locomotor activity induced by injections of carbachol into the tegmental pedunculopontine nucleus and adjacent areas in the rat. Brain Res. 451:1988;119-125.
14. Brudzynski S.M., McLachlan R.S., Girvin J.P. Cholinergically mediated reduction of locomotor activity from the basal forebrain of the rat. Exp. Neurol. 105:1989;197-205.
15. Buscher W., Schugens M., Wagner U., Huston J.P. Interhemispheric relationship between lateral hypothalamic self-stimulation and the region of the nucleus tegmenti pedunculo-pontinus. Brain Res. 487:1989;321-334.
16. Calabresi P., Lacey M.G., North R.A. Nicotinic excitation of rat ventral tegmental neurons in vitro studied by intracellular recording. Br. J. Pharmacol. 98:1989;135-140.
17. Chapman C.A., Yeomans J.S., Blaha C.D., Blackburn J.R. Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus. Neuroscience. 76:1997;177-186.
18. Clarke P.B.S., Hommer D.W., Pert A., Skirboll L.R. Innervation of substantia nigra neurons by cholinergic afferents from pedunculopontine nucleus in the rat: neuroanatomical and electrophysiological evidence. Neuroscience. 23:1987;1011-1019.
19. Costall B., Naylor R.J. A comparison of circling models for the detection of antiparkinsonian activity. Psychopharmacologia. 45:1975;57-64.
20. Creese I., Iversen S.E. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res. 55:1974;369-382.
21. Delfs J.M., Kelly A.E. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience. 39:1990;59-67.
22. Fujimoto K., Ikeguchi K., Yoshida M. Decrease and recovery of choline acetyltransferase activity in medial thalamus and ventral tegmental area after destruction of pedunculopontine nucleus areas in the rat. Neurosci. Res. 9:1990;48-53.
23. T. Futami, K. Takakusaki, S.T. Kitai, Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta, Neurosci. Res. 21 (1995) 331-342.
24. Garcia-Rill E., Kinjo N., Atsuta Y., Ishikawa Y., Webber M., Skinner R.D. Posterior midbrain-induced locomotion. Brain Res. Bull. 24:1990;499-508.
25. Gould E., Woolf N.J., Butcher L.L. Cholinergic projections to the substantia nigra from the peduculopontine and laterodorsal tegmental nuclei. Neuroscience. 28:1989;611-623.
26. Grenhoff J., Svensson T.H. Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;395-398.
27. Jones D.L., Mogenson G.J., Wu M. Injections of dopaminergic, cholinergic, serotonergic and gabergic drugs into the nucleus accumbens: effects on locomotor activity in the rat. Neuropharmacology. 20:1981;39-47.
28. Joyce E.M., Koob G.F. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system. Psychopharmacology. 73:1981;311-313.
29. Kelley A.E., Winnock M., Stinus L. Amphetamine, apomorphine and investigation behavior in the rat: analysis of the structure and pattern of responses. Psychopharmacology. 88:1988;66-74.
30. Kelly P.H., Miller R.J. Interaction of neuroleptic and muscarinic agents with central dopaminergic systems. Br. J. Pharmacol. 54:1975;115-121.
31. O. Kofman, The role of ventral tegmental cholinergic receptors in reward, University of Toronto, Ph.D. Dissertation, 1987.
32. Kofman O., McGlynn S.M., Olmstead M.C., Yeomans J.S. Differential effects of atropine, procaine, and dopamine in the rat ventral tegmentum on lateral hypothalamic rewarding brain stimulation. Behav. Brain Res. 38:1990;55-68.
33. Lacey M.G., Calabresi P., North R.A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J. Pharmacol. Exp. Ther. 253:1991;395-400.
34. Leonard C.S., Llinas R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM-sleep: an in vitro electrophysiological study. Neuroscience. 59:1994;309-330.
35. Leonard C.S., Rhee J., Stutzman G.E., Aoki C. Pharmacological and EM-immunocytochemical evidence for recurrent axon collaterals mediating feedback inhibition to NOS+, cholinergic neurons of the laterodorsal tegmental (LDT) nucleus. Soc. Neurosci. Abstr. 22:1996;147.
36. Luebke J.I., McCarley R.W., Greene R.W. Inhibitory action of muscarinic agonists on neurons in the rat laterodorsal tegmental nucleus in vitro. J. Neurophysiol. 70:1993;2128-2135.
37. Morpurgo C., Theobald W. Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics. Psychopharmacologia. 6:1964;178-191.
38. Mueller K., Peel J.L. Scopolamine produces locomotor stereotypy in an open field but apomorphine does not. Pharmacol. Biochem. Behav. 36:1990;613-617.
39. Myers B., Roberts K.H., Riciputi R.M., Domino E.F. Some effects of muscarinic cholinergic drugs on behaviour and the electrocorticogram. Psychopharmacologia. 5:1964;289-300.
40. Niijima K., Yoshida M. Activation of mesencephalic dopamine neurons by chemical stimulation of the nucleus tegmenti pedunculopontinus pars compacta. Brain Res. 451:1988;163-171.
41. Parker G.C., Inglis W.L., Winn P. A comparison of behaviour following stimulation of the anterior substantia nigra by direct cholinergic agonists and anticholineresterases. Psychopharmacology. 112:1993;242-248.
42. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1986.
43. A. Pert, P.B.S. Clarke, Nicotinic modulation of dopaminergic neurotransmission: functional implications, in: W.R. Martin, G.R. van Loon, E.T. Iwamoto, L. Davis (Eds.), Tobacco Smoking and Nicotine, Plenum, New York, 1987, pp. 169-190.
44. Reavill C., Stolerman I.P. Locomotor activity in rats after administering nicotinic agonists intracerebrally. Br. J. Pharmacol. 99:1990;273-278.
45. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
46. Sanberg P.R., Henault M.A., Hagenmeyer-Houser S.H., Russell K.H. The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print. Behav. Neurosci. 101:1987;131-133.
47. Schmidt W.J. Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology. 90:1986;123-130.
48. Serafin M., Khateb A., Mulethaler M. Opiates inhibit pedunculopontine neurones in guinea pig brainstem slices. Neurosci. Lett. 119:1990;125-128.
49. Setler P., Sarau H., McKenzie G. Differential attenuation of some effects of haloperidol in rats given scopolamine. Eur. J. Pharmacol. 39:1976;117-126.
50. Shannon H.E., Peters S.C. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice. J. Pharmacol. Exp. Ther. 255:1990;549-553.
51. M.M. Singh, S.R. Kay, Pharmacology of central cholinergic mechanisms and schizophrenic disorders, in: Singh et al. (Eds.), Central Cholinergic Mechanisms and Adaptive Functions, Plenum, New York, 1985, pp. 247-308.
52. Stephens D.N., Herberg L.J. Dopamine-acetylcholine 'balance' in nucleus accumbens and corpus striatum and its effect on hypothalamic self-stimulation. Eur. J. Pharmacol. 54:1979;331-339.
53. Thornburg J.E., Moore K.E. Inhibition of anticholinergic drug induced locomotor stimulation in mice by α-methyltyrosine. Neuropharmacology. 12:1973;1179-1185.
54. Tokuno H., Moriizumi T., Kudo M., Nakamura Y. A morphological evidence for monosynaptic projections from the nucleus tegmenti pedunculopontinus pars compacta (TPC) to nigrostriatal projection neurons. Neurosci. Lett. 85:1988;1-4.
55. Vaccarino F.J., Rankin J. Nucleus accumbens CCK can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function. Behav. Neurosci. 103:1989;831-836.
56. Winn P. Cholinergic stimulation of substantia nigra: effects on feeding, drinking and sexual behaviour in the male rat. Psychophamacology. 104:1990;208-214.
57. Winn P., Farrell A., Maconick A., Robbins T.W. Behavioural and pharmacological specificity of the feeding elicited by cholinergic stimulation of the substantia nigra in the rat. Behav. Neurosci. 97:1983;794-809.
58. Yeomans J.S. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology. 12:1995;3-16.
59. J.S. Yeomans, M. Baptista, Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward, Pharmacol. Biochem. Behav., in press.
60. Yeomans J.S., Kofman O., McFarlane V. Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res. 329:1985;19-26.
61. Yeomans J.S., Mathur A., Tampakeras M. Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav. Neurosci. 107:1993;1077-1087.
62. Gardner E.L., Walker L.S., Paredes W. Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat. Psychopharmacology. 110:1993;119-124.
63. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype specific antibodies. J. Neurosci. 11:1991;3218-3226.
64. Mash D.C., Potter L.T. Autoradiographic localization of M1 and M2 muscarinic receptors in the rat brain. Neuroscience. 19:1986;551-564.
65. Vilaro M.T., Wiederhold K.-H., Palacios J.M., Mengod G. Muscarinic m2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience. 47:1992;367-393.